Summary
For Year 2026-27, IOL Chemicals And Pharmaceuticals reports the following shareholding: Total Promoters at 57.48%, Mutual Fund at 0.02%, Insurance at 0%, Foreign Institutional Investors at 1.72%, Domestic Institutional Investors at 0%, and Retail at 40.78%. This breakdown provides a quick snapshot of ownership distribution for IOL Chemicals And Pharmaceuticals in 2026-27.
IOL Chemicals And Pharmaceuticals FAQs
As of 04-2026, the promoter shareholding in IOL Chemicals And Pharmaceuticals stands at 57.48% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of IOL Chemicals And Pharmaceuticals is 1.72% and 0% respectively.
The retail shareholding of the IOL Chemicals And Pharmaceuticals is 40.78%.
Changes in shareholding patterns of IOL Chemicals And Pharmaceuticals can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of IOL Chemicals And Pharmaceuticals are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
IOL Chemicals And Pharmaceuticals Associated Pages
- IOL Chemicals And Pharmaceuticals Share Price
- IOL Chemicals And Pharmaceuticals Share Price chart
- IOL Chemicals And Pharmaceuticals Fundamental Analysis
- IOL Chemicals And Pharmaceuticals Technical Analysis
- IOL Chemicals And Pharmaceuticals Peer Comparison
- IOL Chemicals And Pharmaceuticals Share Price History
- IOL Chemicals And Pharmaceuticals Stock Split
- IOL Chemicals And Pharmaceuticals Dividend
- IOL Chemicals And Pharmaceuticals Board of Directors
